Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (The BRDME Study)

NCT01635790 is registered in ClinicalTrials.gov with Prof. dr. R.O. Schlingemann as lead sponsor.

NCT NCT01635790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01635790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (The BRDME Study)
Lead sponsor
Prof. dr. R.O. Schlingemann
Phase
Phase 2/3
Overall status
Unknown status
Start date
June 30, 2012
Completion date
Not reported
Enrollment
246 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema